Cesca Therapeutics (KOOL) Misses Q2 EPS by 3c

February 12, 2015 4:20 PM EST

Cesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.11), $0.03 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.08 million.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings